The Moderna Inc. headquarters in Cambridge, Massachusetts, on March 26, 2024. Adam Glanzman | Bloomberg | Getty Images Moderna on Thursday said it plans to slash roughly 10% of its global workforce by the end of the year, as Covid shot sales continue to dwindle and the company grapples with uncertainty in the vaccine market. …
Check out the companies making headlines before the bell: Moderna — Shares rose 2% after the biotech company’s experimental flu vaccine showed a positive response in a late-stage trial, opening the way for the standalone shot and a combination Covid shot. Hewlett Packard Enterprise , Juniper Networks — Shares rallied 14% and 8%, respectively, after…
The Moderna Inc. headquarters in Cambridge, Massachusetts, on March 26, 2024. Adam Glanzman | Bloomberg | Getty Images Moderna on Monday said its experimental mRNA-based flu vaccine produced a stronger immune response than a currently available shot in a late-stage trial, clearing a path forward for the product and the company’s separate combination flu and…
The Food and Drug Administration on Monday approved Merck’s shot designed to protect infants from respiratory syncytial virus during their first season of the virus, bringing to market a rival to a similar treatment from Sanofi and AstraZeneca. The decision will allow the company to launch the drug, which will be marketed as Enflonsia, ahead…
Check out the companies making headlines in midday trading. D-Wave Quantum — The quantum computing stock surged more than 26% after announcing its latest computing system called Advantage2. Agilysys — The enterprise software developer for the hospitality industry rallied 21% after topping analysts expectations in its latest quarter. Agilysys reported fiscal fourth-quarter adjusted EBITDA of…
Check out the companies making headlines in midday trading: CoreWeave — Shares of the cloud provider tumbled more than 7% in its second trading session since going public. CoreWeave, which rents out access to Nvidia graphics processing units to other large tech companies, suffered a disappointing debut last week. Nvidia also saw its shares drop…
Rafael Henrique | Lightrocket | Getty Images Shares of major vaccine makers dropped on Monday after a key U.S. health official resigned in protest of Health and Human Services Secretary Robert F. Kennedy Jr.’s views on immunization. The departure of Peter Marks, the Food and Drug Administration’s top vaccine regulator, has raised fresh fears about…
A trader works on the floor of the New York Stock Exchange (NYSE) at the opening bell in New York City on March 10, 2025. Charly Triballeau | Afp | Getty Images The majority of the stocks in the S&P 500 are already in correction territory as the sell-off on Wall Street continues to drag…
Moderna on Friday posted fourth-quarter revenue that beat estimates, but lost more than expected for the period, as the biotech company continues to slash costs and demand for its Covid vaccine falls. It marks another quarter of growing pains for the company, which is racing to launch new products and recover from the rapid decline…
Check out the companies making headlines before the bell. Apple — Shares slipped nearly 2% after Jefferies downgraded the iPhone maker to an underperform rating from hold. Analyst Edison Lee called its AI outlook “subdued” and expects Apple to miss its fiscal first-quarter revenue growth forecast of 5% when reporting earnings later this month. Qorvo…
